billS3827•Event Wednesday, February 11, 2026Analyzed
Financial Disclosure Modernization Act
Neutral
Summary
The Financial Disclosure Modernization Act (S.3827) is an early-stage administrative transparency bill that modifies reporting value categories for federal employee financial disclosures. It contains no funding, procurement, revenue, or cost mechanisms for any publicly traded company. Market impact is zero.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.S.3827 is a procedural transparency bill with zero financial market impact.
- 2.No public company faces any cost, revenue, or regulatory change from this legislation.
- 3.The bill is in early legislative stages with no momentum indicators.
Market Implications
This bill has no market implications. It does not touch any sector, company, or financial instrument. Retail investors should ignore this legislation entirely.
Full Analysis
1) What happened: On February 11, 2026, Sen. Adam Schiff (D-CA) introduced S.3827, the Financial Disclosure Modernization Act. The bill was read twice and referred to the Committee on Homeland Security and Governmental Affairs. It is in the earliest legislative stage with no hearings, markups, or votes scheduled. 2) The money trail: There is no money trail. The bill amends section 13104 of title 5, United States Code, solely to update the reporting value brackets (e.g., adding categories above $1,000,000 for dividends, rents, interest, and capital gains). It authorizes no appropriations, creates no tax credits, establishes no grants, and imposes no procurement requirements. 3) Structural winners and losers: None. The bill applies only to federal employee financial disclosure forms (OGE Form 278e and similar). It does not regulate, tax, subsidize, or contract with any private sector entity. No publicly traded company is affected. 4) Competitive landscape: Not applicable. 5) Timeline: The bill has no committee action beyond referral. Identical companion bill HR7508 has been referred to three House committees (Oversight and Government Reform, House Administration, and Judiciary), all of which are similarly early in the process. Passage in the 119th Congress is uncertain and would require extensive committee markup, floor votes in both chambers, and presidential signature.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight